Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Trump Says He Will Allow States to Import Prescription Drugs to Lower Costs

Reuters Staff  |  November 25, 2019

WASHINGTON (Reuters)—U.S. President Donald Trump said on Friday, Nov. 22, he will soon release a plan to let Florida and other states import prescription medicines to combat high drug prices. He blasted the Democrat-led U.S. House of Representatives for not going far enough in a drug-pricing bill.

“We will soon be putting more options on the table,” Trump wrote in a series of tweets, adding that House Speaker Nancy Pelosi (D-Calif.) “and her Do-Nothing Democrats drug pricing bill doesn’t do the trick.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The tweets were similar to comments the president made on Nov. 15 at a White House event with U.S. Health and Human Services (HHS) Sec. Alex Azar, among other officials. At that meeting, Trump said he would work with Florida Gov. Ron DeSantis on a plan to broaden rules on importing pharmaceuticals into this country.

Drug companies have staunchly opposed such a plan, which has been mulled for years, but never implemented.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“House Republicans are showing real LEADERSHIP and prepared to enact bipartisan solutions for drug prices. Do Nothing Democrats are playing partisan politics with YOUR drug prices! We are READY to work together if they actually want to get something done!,” the President, who faces impeachment by the Democrat-led House of Representatives, said on Twitter.

U.S. prescription drug costs are the highest in the developed world because most other countries negotiate pricing directly with manufacturers, while drug companies are allowed to set their own prices in the United States.

Lowering healthcare costs for U.S. consumers is expected to be a major issue in the 2020 presidential campaign.

Share: 

Filed under:Drug Updates Tagged with:costsdrug costTrump administration

Related Articles

    U.S. States Plan Suit to Block Trump Obamacare Subsidies Cut

    October 16, 2017

    WASHINGTON/SAN FRANCISCO (Reuters)—On Friday, California, New York and others states vowed to sue President Donald Trump’s administration to stop him from scrapping a key component of Obamacare, subsidies to insurers that help millions of low-income people pay medical expenses, even as Trump invited Democratic leaders to negotiate a deal. One day after his administration announced…

    White House Says Trump Opposes Bipartisan Senate Deal on Obamacare

    October 18, 2017

    WASHINGTON (Reuters)—A bipartisan deal from two U.S. senators to stabilize Obamacare by restoring subsidies to health insurers ran into trouble on Wednesday with the White House saying President Donald Trump now opposes it and a senior Senate Republican saying it has stalled. House of Representatives Speaker Paul Ryan also signaled opposition to the deal announced…

    Trump Appears to Be Losing Battle Ahead of Healthcare Vote

    March 23, 2017

    WASHINGTON (Reuters)—U.S. President Donald Trump and Republican congressional leaders appeared on Wednesday to be losing the battle to get enough support in the House of Representatives to pass their Obamacare rollback bill, watched by wary investors in financial markets. The current House Republican rollback plan is scheduled for a floor vote on Thursday but faces…

    Sen. Sanders, Rep. Cummings to Introduce Bill to Lower U.S. Drug Prices

    January 11, 2019

    WASHINGTON (Reuters)—U.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation on Thursday aimed at lowering the cost of prescription drugs for U.S. consumers. Democrats have been critical of efforts by the Trump administration to bring down drug prices after President Donald Trump promised to do so during his campaign and since being…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences